Please provide your email address to receive an email when new articles are posted on . Compared with a dual therapy inhaler, a triple therapy inhaler improved inspiratory capacity in those with COPD.
The MHRA has authorised GSK’s Nucala (mepolizumab) in the UK as an add‑on maintenance treatment for adults with uncontrolled ...
A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials, ...
Are you finding that your chronic obstructive pulmonary disease (COPD) is making it harder to do the things you enjoy? Canceling plans more often? Missing work due to flare-ups? It could mean your ...
Ohtuvayre (ensifentrine), a drug approved in 2024 to treat chronic obstructive pulmonary disorder (COPD), is receiving high marks from doctors and patients. Ohtuvayre is the first new inhaled COPD ...
The approval is based on two placebo-controlled phase 3 studies, which showed mepolizumab significantly reduced the annualised rate of moderate/severe exacerbations and time to first moderate/severe ...
Select your location to view local American Lung Association events and news near you.
We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...
Woman’s World has affiliate partnerships. We receive compensation when you click on a link and make a purchase. Learn more! Sure, having a cold or respiratory infection can temporarily make it harder ...
Chronic obstructive pulmonary disease (COPD) makes it hard to breathe. Narrowed airways can make you cough, wheeze, and feel short of breath. It can affect how you exercise, work, and do other daily ...
Pharma giant GSK has received regulatory approval in China for its Nucala treatment for adults with inadequately controlled ...
In addition, symptoms and effective treatments can change quite a bit as the disease gets worse, so it’s good to stay vigilant and check in with your doctor on a regular basis. Wherever you are on ...